AXSM

Axsome Therapeutics Inc.

Price

$218.20

return (12m)

96.06%

p/e

-58.23

p/bv

133.96

DIVIDEND YIELD

0.00%

AXSM price

Axsome Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AXSM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.27%

3 months

-6.61%

1 year

96.06%

2 years

141.69%

5 years

912.06%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AXSM

Valuation

P/E

-58.23

Sector -2.19

Industry 1.21

P/BV

133.96

Sector 2.22

Industry 2.11

P/Revenue (PSR)

14.37

Sector 2.01

Industry 0.78

EV/EBITDA

-234.33

Sector -17.81

Industry -25.30

EV/EBIT

-220.69

Sector -26.72

Industry -18.04

P/EBITDA

-63.36

Sector 0.36

Industry 0.18

P/EBIT

-59.97

Sector -3.34

Industry 1.26

P/Total Assets

14.65

Sector 1.23

Industry 0.86

P/Net Current Assets

-517.34

Sector -27.35

Industry -12.37

P/Working Capital

56.90

Sector -4.54

Industry -49.48

EPS

-3.69

Sector -0.87

Industry -0.55

BVPS

1.60

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

93.24%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-21.41%

Sector -323.65%

Industry -73.39%

EBIT Margin

-22.74%

Sector -194.57%

Industry -11.94%

Operating Margin

-23.55%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-24.68%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.29

Sector 0.12

Industry 0.22

Profitability

ROE

-230.06%

Sector -33.82%

Industry -37.56%

ROA

-25.17%

Sector -29.63%

Industry -17.56%

ROIC

-93.08%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.43

Sector 1.84

Industry 1.14

Net Debt / EBITDA

4.32

Sector -1.47

Industry -31.86

Net Debt / EBIT

4.07

Sector -1.32

Industry 2.06

Net Debt / Equity

-2.42

Sector -0.35

Industry 0.14

Gross Debt / Equity

1.42

Sector 0.14

Industry 0.51

Equity/Assets

0.11

Sector 0.42

Industry 0.25

Liabilities/Assets

0.89

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

8.00%

Sector -

Industry -

Fundamentals AXSM

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AXSM Axsome Therapeutics Inc.	$218.20	96.35%	0.00%	-58.23	133.96	-230.06%	-24.68%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AXSM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Axsome Therapeutics

Axsome Therapeutics Inc.

Average Investor10 user rating

4.0 (6 people)

United States

14 years

Founded: 2012

2015

Time since IPO - 11 years

60

Employees

Axsome Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $11.16 billion, with shareholders equity totaling $83.30 million.

The company employs approximately 60 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Axsome Therapeutics Inc. reported $776.57 million in revenue, generating net income of $-191.64 million.

Key financial metrics include a P/E ratio of -58.23, a price-to-book (P/B) ratio of 133.96, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AXSM.

Market cap

$11.16 billion

Net worth

$83.30 million

$83,300,000.00

Assets

$761.45 million

$761,450,000.00

Total Shares Outstanding

52.00 million

52,000,000

Average Daily Trading Volume

$932.41 Thousand

$932,408.00

Sector

Health

Industry

Pharmaceutical Products

AXSM

AXSM revenue and profits

Financial Results AXSM

DRAG THE FRAME TO SEE MORE DATA

AXSM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87